SEC Form 4 · accession 0000899243-18-020281
CONSTELLATION PHARMACEUTICALS INC · CNST
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Adrian Senderowicz
Officer — Chief Medical Officer
Period of report
Jul 19, 2018
Accepted (ET)
Jul 20, 2018 · 5:40 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001434418
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $11.50 | Jul 19, 2018 | A | 19,075 | A | — | Jul 18, 2028 | Common Stock | 19,075 | 19,075 | D |
Explanation of responses
- F1This option was granted on July 19, 2018 and is scheduled to vest in equal quarterly installments through July 19, 2022, subject to continued service.